Literature DB >> 20810540

Characterization of human flavin-containing monooxygenase (FMO) 3 and FMO5 expressed as maltose-binding protein fusions.

Robert R Reddy1, Erik C Ralph, Meike S Motika, Jun Zhang, John R Cashman.   

Abstract

The flavin-containing monooxygenase (FMO) family of enzymes oxygenates nucleophilic xenobiotics and endogenous substances. Human FMO3 and FMO5 are the predominant FMO forms in adult liver. These enzymes are naturally membrane-bound, and recombinant proteins are commercially available as microsomal preparations from insect cells (i.e., Supersome FMO). As an alternative, FMO3 has previously been expressed as a soluble protein, through use of an N-terminal maltose-binding protein (MBP) fusion. In the current study, MBP fusions of both human FMO3 and FMO5 were prepared to >90% purity in the presence of detergent and characterized for biochemical and kinetic parameters, and the parameters were compared with those of Supersome FMO samples. Although MBP-FMO enzymes afforded lower rates of turnover than the corresponding Supersome FMOs, both types of FMO showed identical substrate dependencies and similar responses to changes in assay conditions. Of interest, the FMO3 enzymes showed a 2-fold activation of k(cat)/K(m) in the presence of Triton X-100. Oligomeric analysis of MBP-FMO3 also showed disassociation from a high-order oligomeric form to a monomeric status in the presence of Triton X-100. This report serves as the first direct comparison between Supersome FMOs and the corresponding MBP fusions and the first report of a detergent-based activation of k(cat)/K(m) that corresponds to changes in oligomerization.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20810540      PMCID: PMC2993457          DOI: 10.1124/dmd.110.033639

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  30 in total

1.  Maltose-binding protein as a solubility enhancer.

Authors:  Jeffrey D Fox; David S Waugh
Journal:  Methods Mol Biol       Date:  2003

2.  C-Terminal truncation of rabbit flavin-containing monooxygenase isoform 2 enhances solubility.

Authors:  Sharon K Krueger; Lisbeth K Siddens; Marilyn C Henderson; Jonathan E VanDyke; P Andrew Karplus; Clifford B Pereira; David E Williams
Journal:  Arch Biochem Biophys       Date:  2006-03-29       Impact factor: 4.013

3.  Identification of human drug-metabolizing enzymes involved in the metabolism of SNI-2011.

Authors:  T Washio; H Arisawa; K Kohsaka; H Yasuda
Journal:  Biol Pharm Bull       Date:  2001-11       Impact factor: 2.233

4.  Amylose affinity chromatography of maltose-binding protein: purification by both native and novel matrix-assisted dialysis refolding methods.

Authors:  Leonard K Pattenden; Walter G Thomas
Journal:  Methods Mol Biol       Date:  2008

Review 5.  Control of catalysis in flavin-dependent monooxygenases.

Authors:  Bruce A Palfey; Claudia A McDonald
Journal:  Arch Biochem Biophys       Date:  2009-11-26       Impact factor: 4.013

Review 6.  Role of flavin-containing monooxygenase in drug development.

Authors:  John R Cashman
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-12       Impact factor: 4.481

Review 7.  Flavin-containing monooxygenase 3 and human disease.

Authors:  Meike S Motika; Jun Zhang; John R Cashman
Journal:  Expert Opin Drug Metab Toxicol       Date:  2007-12       Impact factor: 4.481

8.  Novel variants of the human flavin-containing monooxygenase 3 (FMO3) gene associated with trimethylaminuria.

Authors:  Meike S Motika; Jun Zhang; Xueying Zheng; Kiersten Riedler; John R Cashman
Journal:  Mol Genet Metab       Date:  2009-02-27       Impact factor: 4.797

9.  Functional characterization of genetic variants of human FMO3 associated with trimethylaminuria.

Authors:  Catherine K Yeung; Elinor T Adman; Allan E Rettie
Journal:  Arch Biochem Biophys       Date:  2007-05-02       Impact factor: 4.013

10.  Identification of the human enzymes involved in the oxidative metabolism of dasatinib: an effective approach for determining metabolite formation kinetics.

Authors:  Lifei Wang; Lisa J Christopher; Donghui Cui; Wenying Li; Ramaswamy Iyer; W Griffith Humphreys; Donglu Zhang
Journal:  Drug Metab Dispos       Date:  2008-06-12       Impact factor: 3.922

View more
  1 in total

1.  Xanthates: Metabolism by Flavoprotein-Containing Monooxygenases and Antimycobacterial Activity.

Authors:  Stanislav G Yanev; Tsveta D Stoyanova; Violeta V Valcheva; Paul R Ortiz de Montellano
Journal:  Drug Metab Dispos       Date:  2018-05-18       Impact factor: 3.922

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.